These courses are intended for internal hospital staff.

Activity Description:

This session provides an evidence-based deep dive into the critical minutes following traumatic injury, focusing on the physiological transition from "clear fluids" to "balanced resuscitation." Participants will evaluate the latest clinical standards for managing hemorrhagic shock, emphasizing the early identification of coagulopathy and the strategic reversal of anticoagulation in the prehospital environment. 

Target Audience: 

CME activities are designed to serve the professional and educational needs of physicians.  The target audience is Emergency Medical Services (EMS), Paramedics, Pre-Hospital Clinicians, Medical First Responders, Emergency Medical Technicians (EMTs), Air-Ground Ambulance Services, and Service Line Representatives. 

Learning Objectives:

1. Able to identify the evaluation and rapid assessment in the initial resuscitation of shock. 
2. List fluid resuscitations differences associated with neurogenic, hemorrhagic, and septic shock.
3. Identify differences in colloid and crystalloid resuscitation.
4. Determine the appropriate use of TXA.

Moderator:

Kaysie Banton, MD, MHA, FACS, FCCM

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties in control of content are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.​